Bridgeway Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bridgeway Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,000	Closed	-$40K	–	1499
2023 Q1	$40K	Hold	25,000	–	–	﹤0.01%	1327
2022 Q4	$49K	Sell	25,000 -156	-0.6%	-$385	﹤0.01%	1298
2022 Q3	$88K	Hold	25,156	–	–	﹤0.01%	1297
2022 Q2	$86K	Buy	+25,156	New	+$139K	﹤0.01%	1246
2021 Q3	–	Sell	-12,423	Closed	-$518K	–	1372
2021 Q2	$518K	Sell	12,423 -5,167	-29%	-$265K	0.01%	1056
2021 Q1	$1.15M	Buy	17,590 +10,000	+132%	+$698K	0.02%	809
2020 Q4	$499K	Buy	7,590 +7,047	+1,298%	+$459K	0.01%	955
2020 Q3	$29K	Buy	+543	New	+$41.5K	﹤0.01%	1308
2020 Q2	–	Sell	-6,703	Closed	-$344K	–	1429
2020 Q1	$344K	Sell	6,703 -4,047	-38%	-$423K	0.01%	881
2019 Q4	$884K	Buy	10,750 +2,694	+33%	+$189K	0.01%	768
2019 Q3	$689K	Sell	8,056 -2,104	-21%	-$225K	0.01%	836
2019 Q2	$1.29M	Sell	10,160 -8,290	-45%	-$1.19M	0.02%	656
2019 Q1	$3.33M	Sell	18,450 -5,686	-24%	-$823K	0.04%	349
2018 Q4	$2.68M	Buy	24,136 +1,356	+6%	+$177K	0.04%	394
2018 Q3	$3.08M	Buy	22,780 +2,651	+13%	+$365K	0.03%	468
2018 Q2	$2.78M	Sell	20,129 -97	-0.5%	-$13.3K	0.03%	503
2018 Q1	$2.79M	Buy	20,226 +340	+2%	+$46.3K	0.03%	478
2017 Q4	$2.45M	Buy	19,886 +2,903	+17%	+$399K	0.03%	526
2017 Q3	$2.32M	Sell	16,983 -1,520	-8%	-$229K	0.03%	540
2017 Q2	$3.25M	Buy	18,503 +1,791	+11%	+$255K	0.04%	388
2017 Q1	$2M	Buy	16,712 +14,379	+616%	+$1.5M	0.02%	568
2016 Q4	$228K	Buy	2,333 +1,246	+115%	+$114K	﹤0.01%	1292
2016 Q3	$102K	Buy	+1,087	New	+$109K	﹤0.01%	1379
2016 Q2	–	Sell	-4,953	Closed	-$594K	–	1490
2016 Q1	$594K	Sell	4,953 -2,700	-35%	-$284K	0.01%	971
2015 Q4	$912K	Sell	7,653 -2,689	-26%	-$347K	0.02%	800
2015 Q3	$1.76M	Sell	10,342 -93	-0.9%	-$17.8K	0.04%	523
2015 Q2	$2.02M	Buy	10,435 +22	+0.2%	+$4.08K	0.04%	511
2015 Q1	$1.54M	Hold	10,413	–	–	0.03%	622
2014 Q4	$1.62M	Sell	10,413 -2,434	-19%	-$351K	0.04%	588
2014 Q3	$1.84M	Buy	12,847 +5,367	+72%	+$778K	0.05%	514
2014 Q2	$976K	Hold	7,480	–	–	0.03%	781
2014 Q1	$916K	Hold	7,480	–	–	0.03%	793
2013 Q4	$794K	Hold	7,480	–	–	0.02%	834
2013 Q3	$839K	Buy	7,480 +2,833	+61%	+$321K	0.03%	795
2013 Q2	$524K	Buy	+4,647	New	+$568K	0.02%	921

Other funds holding SRGA

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bridgeway Capital Management's SRGA Position: Q2 2023 in Review

Bridgeway Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 25,000 shares — an estimated $40K sold.

Bridgeway Capital Management first reported a position in SRGA in Q2 2013 and held it in 35 quarters. The position peaked at $3.33M in Q1 2019. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

Bridgeway Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Bridgeway Capital Management sold 25,000 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $40K.
Bridgeway Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 35 quarters.
Bridgeway Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $3.33M in Q1 2019.
25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.